Biodesix Inc risk profile
53 Elevated one input has moved against it
Measured 21 October 2026 from BDSX's filed statements. Recomputed nightly.
53 (Elevated), driven by Cash conversion at 100, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 62 | Stretched | Volatile | One-year price volatility — 108.0% |
| Operating pressure | 1 | Contained | Stable | Input-cost exposure — 0.01 |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.01x |
| Leverage and coverage | 88 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 64 | Stretched | Stable | Operating-margin gap against peers — -28.1 percentage points |
| Concentration | 38 | Normal | Easing | Customer concentration — 1,024 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.